Santos and colleagues discovered that CSCs secrete exosomal miRNA-155, which can lead to the downregulation of C/EBP-β, thereby inhibiting the expression of TGF-β, C/EBP-β, and FOXO3a, resulting in the development of EMT and chemoresistance in cancer cells [62]. This evidence concerns the gene CEBPB and cancer.